| 000 | 01537nam a2200337Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625153901.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-12615 | ||
| 245 | 1 | 0 | _aStructure-activity relationship (SAR)of parthenin analogues with pro-apoptotic activity: Development of novel anti-cancer leads |
| 490 | 0 | _vBioorganic & Medicinal Chemistry Letters, 19(15), p.4394-4398, 2009 | |
| 520 | 3 | _aAnalogues of parthenin were synthesized by substitutions at different reaction centres to establish a structure-activity relationship (SAR). Some of the molecules have displayed significant cytotoxicity in human cervical carcinoma (HeLa)and human myeloid leukemia (HL-60)cells. A few of the compounds also induced apoptosis in HL-60 cells measured in terms of sub-Go/G1 DNA fraction. Also one of the lead molecules has been shown to be the inhibitor of both telomerase and topoisomerase-II. | |
| 650 | 1 | 4 | _aCYTOTOXICITY |
| 650 | 1 | 4 | _aAPOPTOSIS |
| 650 | 1 | 4 | _aTOPOISOMERASE-II |
| 650 | 1 | 4 | _aTELOMERASE |
| 650 | 1 | 4 | _aSAR |
| 650 | 1 | 4 | _aPARTHENIN |
| 700 | 1 | 2 | _aShah, B.A. |
| 700 | 1 | 2 | _aKaur, R. |
| 700 | 1 | 2 | _aGupta, P. |
| 700 | 1 | 2 | _aKumar, A. |
| 700 | 1 | 2 | _aSethi, V.K. |
| 700 | 1 | 2 | _aAndotra, S.S. |
| 700 | 1 | 2 | _aSingh, J. |
| 700 | 1 | 2 | _aSingh, J. |
| 700 | 1 | 2 | _aTaneja, S.C. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1npSfPkTsDm20z3wr4KuqSBTBH-xCQRuB/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c46822 _d46822 |
||